Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
[31] RCT Crossover design	30 people; diagnosed by IHS criteria[17]	Adverse effects with maprotiline with placebo Absolute results not reported
[32] RCT	114 people; diagnosed by criteria of the Ad Hoc Committee 1962[2] (80% consistent with IHS criteria)	Adverse effects with mianserin with clomipramine with placebo Absolute results not reported